Biotechnology News

May 2, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Frank Karbe, the company’s executive vice president and chief financial officer, will present at the upcoming Deutsche Bank Securities 37th Annual...

May 2, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), an autologous cellular therapeutic company focused on the development of innovative products for aesthetic, medical and scientific applications, announced today that David...

May 2, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River announces first-quarter 2012 results

May 2, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo will host a webcast and conference call to discuss first quarter 2012 highlights and results on May 9, 2012, at 5 pm Eastern.

May 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the Deutsche Bank 37th Annual Health Care Conference on Tuesday, May 8, 2012 at 11:20 a.m. EDT and...

May 2, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Bank of America Merrill Lynch 2012 Healthcare Conference on Wednesday, May 16, 2012, at 11:20 a.m. PT. The live webcast of Baxter’...

May 2, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the first quarter ended March 31, 2012, and provided an operating forecast and program updates. "2012 has opened strong for Ligand...

May 2, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2012. Revenues for the quarter were $10.4 million, compared to $0.4 million for the same period in...

May 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Bank of America Merrill Lynch 2012...

May 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that it will host a conference call and Webcast on Thursday, May 10, 2012 at 4:30 p.m. ET to discuss the Company’s first quarter results. To access the live...

May 2, 2012

WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Azelon Pharmaceuticals, Inc., a biopharmaceutical company developing treatments for osteoporosis, announces the completion of a phase 2a trial comparing nasal spray ZT-034 to Forteo administered by...

May 2, 2012

SAN ANTONIO--(BUSINESS WIRE)--The KCI Graftjacket(R) Regenerative Tissue Matrix Reimbursed by Medicare in Eight Midwestern States; Approximately 7.5 Million People Gain Access to Proven Safe, Effective Treatment Option for DFUs

May 2, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--Press and analysts attending CLEO: 2012 are invited to the press luncheon titled "Biophotonics for Cancer Detection, Diagnosis, and Treatment", May 9 at noon in the San Jose Convention Center.

May 2, 2012

PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC today announced the recruiting of key scientific executives and the completion of a significant laboratory build-out as part of its expanded activity in pharmaceutical discovery. In addition to...

May 2, 2012

BALTIMORE--(BUSINESS WIRE)--Profectus BioSciences receives NIAID grant to develop a vesicular stomatitis virus-vectored vaccine for Ebola and Marburg viruses.

May 2, 2012

CARY, N.C.--(BUSINESS WIRE)--Pharma decision-makers weigh in on topics effecting patient recruitment, including: drivers and barriers to success, valuable recruitment channels and methodologies, and the use of service providers.

May 2, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Xcellerex, Inc. has launched its XDUO™ Quad™ single-use mixing system supporting single-use biomanufacturing in upstream and downstream mixing applications and unit operations.

May 2, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information’s study, “Market Access Management: Building Teams that Deliver Value to Payers,” says a quarter of pharmaceutical companies now fund and staff a separate Market Access group...

May 2, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG) JAD award 2012 (http://mb.cision.com/...

May 2, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience's LipiFlow treatment is emerging as the new standard of care for evaporative dry eye and will be available in 40 premier ophthalmic practices in North America by July, 2012.

May 2, 2012

PARIS & PHILADELPHIA--(BUSINESS WIRE)--Nanobiotix and Thomas Jefferson University Start Research Collaboration.

May 2, 2012

MORGAN HILL, Calif.--(BUSINESS WIRE)--Aragen Bioscience Inc. and XOMA Corporation announce a partnership to offer XOMA’s antibody humanization technology, Human Engineering™, through Aragen Bioscience’s contract services.

May 2, 2012

HERCULES, Calif.--(BUSINESS WIRE)--Using Next Generation Sequencing, Eureka has developed low cost, low density marker assays to address the gap between traditional array technologies and multiplex PCR for clinical and AgBio markets

May 2, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Design and technology consultancy Cambridge Design Partnership today announces that it has completed a research project to identify the future of medical technology to treat Atrial Fibrillation

May 2, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that Massachusetts Eye and Ear (“Mass. Eye and Ear”) has received institutional review board...

May 2, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc., the leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a research collaboration with Merck, through a subsidiary....

May 2, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends finds that over half of Infectious Disease (ID) specialists that report awareness of Teflaro have initiated use of the drug.

May 2, 2012

TORONTO--(BUSINESS WIRE)--Adoption of premium-priced devices will drive market growth in the European transcatheter embolization and occlusion (TEO) market.

May 2, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, and The Dow Chemical Company (NYSE: DOW), announced today that they have entered into a contingent offtake agreement in which...

May 2, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics today announced Kevin C. O’Boyle has been elected as a member of the Company’s Board and will serve as Chair of the Audit Committee. Mr. O’Boyle has over 27 years’ financial and operational...

May 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus advancing Z160, in multiple chronic pain clinical trials. Formulation selected - will initiate two Phase 2a clinical trials; the first to begin enrolling in the third quarter of 2012.

May 2, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics announces publication of new results in the journal Leukemia demonstrating therapeutic delivery of microRNA-34 mimics

May 2, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company's presentations at two upcoming investment conferences. Illumina will webcast its presentation at the Robert W. Baird Growth Stock...

May 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) announced today preliminary data from the exploratory, randomized Phase 2 study comparing the combination of ficlatuzumab and gefitinib, an EGFR tyrosine kinase inhibitor...

May 2, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG) Presentation of results for first quarter 2012 will take place 09:00 (Norwegian time), Wednesday 9 May at Felix Conference Centre, Bryggetorget 3, Aker brygge in Oslo. The...

May 2, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Target Amarantus BioSciences Reports Positive Pre-Clinical Results of Parkinson’s Treatment

May 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro accelerated cross-linking science to be featured at ARVO.

May 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Deutsche Bank 37th Annual Health Care Conference. The live presentation will occur...

May 1, 2012

NEW YORK & CARMIEL, Israel--(BUSINESS WIRE)--Pfizer Inc.(NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-AMEX:PLX, TASE:PLX) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved ELELYSO™ (taliglucerase...

May 1, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the first patient has been dosed in a Phase 3 clinical trial evaluating the efficacy and safety of GS-1101 (formerly CAL-101). GS-1101 is an...

May 1, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the Deutsche Bank Annual Health Care Conference on Monday May 7,...

May 1, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Deutsche Bank 37th Annual Health Care Conference in Boston. John F. Milligan, PhD, Gilead’s...

May 1, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today it will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Tuesday, May 15, 2012 at 11:20 a.m. (PT) / 2:20 p.m. (ET) in Las Vegas. The...

May 1, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $58.6 million for the first...

May 1, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company focused on the development and commercialization of Feraheme® (ferumoxytol) Injection for intravenous (IV) use to treat iron...

May 1, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter ended March 31, 2012. Total revenues for the first quarter of 2012 were $2.3 million, a decrease of $0.8 million from the...

May 1, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announces financial results for the first quarter ended March 31, 2012.

May 1, 2012

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market, today reported financial results for its first...

May 1, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that it has completed the previously announced...